Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 7
2009 12
2010 6
2011 4
2012 16
2013 15
2014 27
2015 19
2016 19
2017 47
2018 38
2019 17
2020 27
2021 13
2022 11
2023 11
2024 16
2025 23
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

295 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and tolerability of pharmacological prophylaxis for migraine headaches: a systematic review and network meta-analysis of randomised controlled trials.
Khalili M, Haghdoost F, Liaghatdar A, Torabiardakani K, Mahdian F, Levit T, Moradi S, Hedayati E, Ahmadi F, Khademioore S, Atkin-Jones T, Patil V, Mirzayeh Fashami F, Mehmandoost S, Couban RJ, Prasad K, Fereshtehnejad SM, Buckley N, Busse JW, Sadeghirad B. Khalili M, et al. Among authors: fereshtehnejad sm. BMJ Evid Based Med. 2026 Jun 3:bmjebm-2025-114222. doi: 10.1136/bmjebm-2025-114222. Online ahead of print. BMJ Evid Based Med. 2026. PMID: 42236149
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism.
Martinez-Valbuena I, Emamikhah M, Olszewska DA, Weber SK, Schnell S, Fereshtehnejad SM, Reyes NGD, Sousa M, Di Luca DG, Ta J, Anastassiadis C, Li J, Sasitharan J, Bhakta P, Visanji NP, Fox SH, Mollenhauer B, Tartaglia MC, Kovacs GG, Lang AE. Martinez-Valbuena I, et al. Among authors: fereshtehnejad sm. Nat Med. 2026 May 19. doi: 10.1038/s41591-026-04398-3. Online ahead of print. Nat Med. 2026. PMID: 42157002
Olfactory decline in aging: longitudinal trajectories and associations with cognitive decline and postmortem neuropathology.
Tremblay C, Choudhury P, Driver-Dunckley E, Alasmar Z, Serrano GE, Shill HA, Mehta S, Ho A, Fereshtehnejad SM, Shprecher D, Lorenzini I, Belden CM, Atri A, Adler CH, Beach TG, Dadar M, Zeighami Y. Tremblay C, et al. Among authors: fereshtehnejad sm. medRxiv [Preprint]. 2026 Apr 28:2026.04.27.26351817. doi: 10.64898/2026.04.27.26351817. medRxiv. 2026. PMID: 42094133 Free PMC article. Preprint.
Effectiveness and Tolerability of Pharmacologic Prophylaxis for Chronic Migraine : A Systematic Review of Randomized Controlled Trials.
Khalili M, Haghdoost F, Liaghatdar A, Torabiardakani K, Mahdian F, Levit T, Moradi S, Hedayati E, Ahmadi F, Khademioore S, Atkin-Jones T, Sofi-Mahmudi A, Patil V, Fashami FM, Mehmandoost S, Kahlon HS, Couban RJ, Prasad K, Fereshtehnejad SM, Buckley N, Busse JW, Sadeghirad B. Khalili M, et al. Among authors: fereshtehnejad sm. Ann Intern Med. 2026 Jun;179(6):823-834. doi: 10.7326/ANNALS-25-02221. Epub 2026 May 5. Ann Intern Med. 2026. PMID: 42081823 Review.
Effectiveness and tolerability of pharmacological prophylaxis in migraine patients with prior preventive treatment failure: A systematic review and network meta-analysis of randomized controlled trials.
Khalili M, Haghdoost F, Liaghatdar A, Torabiardakani K, Mahdian F, Atkin-Jones T, Levit T, Moradi S, Hedayati E, Ahmadi F, Khademioore S, Sofi-Mahmudi A, Patil V, Fashami FM, Mehmandoost S, Couban RJ, Prasad K, Fereshtehnejad SM, Sadeghirad B. Khalili M, et al. Among authors: fereshtehnejad sm. Cephalalgia. 2026 Apr;46(4):3331024261441287. doi: 10.1177/03331024261441287. Epub 2026 Apr 21. Cephalalgia. 2026. PMID: 42011527 Review.
Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay.
Brooker SM, Pasquini J, Choi SH, Lafontant DE, Fereshtehnejad SM, Zeighami Y, Grillo P, Riboldi GM, Azizi H, Moqadam R, Kang UJ, Nudelman KNH, Siderowf A, Tanner CM, Tropea TF, Foroud T, Chahine LM, Mollenhauer B, Merchant KM, Galasko D, Coffey CS, Dobkin RD, Brown EG, Alcalay RN, Weintraub D, Marek K, Simuni T, Gonzalez-Latapi P, Pavese N, Poston KL; Parkinson's Progression Markers Initiative. Brooker SM, et al. Among authors: fereshtehnejad sm. Mov Disord. 2026 May;41(5):1114-1127. doi: 10.1002/mds.70197. Epub 2026 Jan 28. Mov Disord. 2026. PMID: 41603617 Free PMC article.
295 results